Concepts (207)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Neuraminidase | 3 | 2018 | 289 | 0.88 | Why? |
| Influenza A Virus, H1N1 Subtype | 7 | 2020 | 2984 | 0.84 | Why? |
| Nucleic Acid Denaturation | 1 | 2019 | 29 | 0.84 | Why? |
| Influenza B virus | 4 | 2019 | 815 | 0.84 | Why? |
| Receptors, CCR5 | 1 | 2018 | 186 | 0.66 | Why? |
| Influenza, Human | 10 | 2019 | 10779 | 0.62 | Why? |
| Sequence Deletion | 1 | 2018 | 674 | 0.54 | Why? |
| Brazil | 15 | 2021 | 12582 | 0.50 | Why? |
| Drug Resistance, Viral | 3 | 2018 | 1083 | 0.49 | Why? |
| Climate | 1 | 2018 | 557 | 0.48 | Why? |
| Polymorphism, Genetic | 1 | 2018 | 1074 | 0.44 | Why? |
| Enzyme Inhibitors | 3 | 2018 | 1881 | 0.43 | Why? |
| Oseltamivir | 2 | 2017 | 583 | 0.35 | Why? |
| Seasons | 4 | 2019 | 4071 | 0.33 | Why? |
| Influenza Vaccines | 2 | 2019 | 2941 | 0.28 | Why? |
| Hemagglutinin Glycoproteins, Influenza Virus | 2 | 2019 | 511 | 0.28 | Why? |
| Morbillivirus | 1 | 2003 | 27 | 0.27 | Why? |
| Mutation | 3 | 2021 | 12376 | 0.26 | Why? |
| Genetic Predisposition to Disease | 1 | 2018 | 4027 | 0.26 | Why? |
| Real-Time Polymerase Chain Reaction | 3 | 2021 | 11367 | 0.23 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2021 | 13720 | 0.22 | Why? |
| Cytoplasmic Vesicles | 1 | 2021 | 74 | 0.22 | Why? |
| Paracoccidioidomycosis | 1 | 2020 | 28 | 0.21 | Why? |
| Lipid Droplets | 1 | 2020 | 75 | 0.21 | Why? |
| Influenza A virus | 3 | 2018 | 2234 | 0.20 | Why? |
| Class Ib Phosphatidylinositol 3-Kinase | 1 | 2018 | 2 | 0.19 | Why? |
| Inflammation Mediators | 2 | 2021 | 2654 | 0.19 | Why? |
| Intracranial Hypertension | 1 | 2020 | 111 | 0.19 | Why? |
| Cytopathogenic Effect, Viral | 1 | 2021 | 635 | 0.18 | Why? |
| Chickenpox Vaccine | 1 | 2019 | 59 | 0.18 | Why? |
| Molecular Epidemiology | 2 | 2021 | 1638 | 0.18 | Why? |
| Measles | 2 | 2019 | 608 | 0.18 | Why? |
| Atazanavir Sulfate | 1 | 2020 | 213 | 0.18 | Why? |
| Hospitals | 1 | 2018 | 11793 | 0.18 | Why? |
| Pets | 1 | 2021 | 314 | 0.17 | Why? |
| Nervous System Diseases | 3 | 2021 | 4092 | 0.17 | Why? |
| DNA-Directed RNA Polymerases | 1 | 2018 | 239 | 0.17 | Why? |
| Sanitation | 1 | 2020 | 403 | 0.16 | Why? |
| Poverty Areas | 1 | 2021 | 556 | 0.15 | Why? |
| Population Surveillance | 4 | 2018 | 4967 | 0.15 | Why? |
| Measles-Mumps-Rubella Vaccine | 1 | 2019 | 282 | 0.15 | Why? |
| Antiviral Agents | 7 | 2020 | 41703 | 0.14 | Why? |
| Costs and Cost Analysis | 1 | 2019 | 694 | 0.14 | Why? |
| Sewage | 1 | 2020 | 591 | 0.14 | Why? |
| Paramyxoviridae | 1 | 2014 | 67 | 0.14 | Why? |
| Rubella | 2 | 2019 | 127 | 0.14 | Why? |
| Rhinovirus | 1 | 2020 | 979 | 0.14 | Why? |
| Human bocavirus | 1 | 2014 | 142 | 0.13 | Why? |
| Gene Frequency | 1 | 2018 | 1210 | 0.13 | Why? |
| Vaccination | 2 | 2018 | 19050 | 0.12 | Why? |
| Alleles | 1 | 2018 | 1557 | 0.12 | Why? |
| Vero Cells | 4 | 2021 | 14117 | 0.12 | Why? |
| Child, Preschool | 7 | 2021 | 36283 | 0.11 | Why? |
| Rubella Vaccine | 1 | 2011 | 17 | 0.11 | Why? |
| Bayes Theorem | 1 | 2021 | 3237 | 0.11 | Why? |
| Spike Glycoprotein, Coronavirus | 2 | 2021 | 37182 | 0.11 | Why? |
| Orthomyxoviridae Infections | 1 | 2018 | 1001 | 0.11 | Why? |
| Infant | 6 | 2021 | 30274 | 0.10 | Why? |
| Inflammation | 4 | 2020 | 13255 | 0.10 | Why? |
| Virion | 1 | 2018 | 1444 | 0.10 | Why? |
| Blood Donors | 1 | 2003 | 2956 | 0.10 | Why? |
| Waste Water | 1 | 2020 | 2185 | 0.10 | Why? |
| Hospitalization | 3 | 2019 | 54280 | 0.10 | Why? |
| Humans | 32 | 2021 | 930598 | 0.10 | Why? |
| Genome, Viral | 2 | 2021 | 13157 | 0.09 | Why? |
| Adult | 14 | 2021 | 244371 | 0.09 | Why? |
| Influenzavirus B | 1 | 2008 | 56 | 0.09 | Why? |
| Influenzavirus A | 1 | 2008 | 66 | 0.09 | Why? |
| Epidemiological Monitoring | 2 | 2018 | 3493 | 0.09 | Why? |
| Young Adult | 9 | 2021 | 93724 | 0.08 | Why? |
| Child | 7 | 2021 | 70012 | 0.08 | Why? |
| Adolescent | 8 | 2021 | 86841 | 0.08 | Why? |
| Genotype | 1 | 2018 | 4697 | 0.08 | Why? |
| Diagnosis, Differential | 1 | 2020 | 7220 | 0.08 | Why? |
| Cities | 1 | 2018 | 4937 | 0.07 | Why? |
| Betacoronavirus | 7 | 2020 | 204454 | 0.07 | Why? |
| Ritonavir | 1 | 2020 | 4212 | 0.07 | Why? |
| Male | 17 | 2021 | 367725 | 0.07 | Why? |
| Respiratory Tract Infections | 2 | 2018 | 6817 | 0.07 | Why? |
| Immunization Programs | 1 | 2018 | 2006 | 0.07 | Why? |
| Biological Evolution | 1 | 2010 | 641 | 0.07 | Why? |
| Public Health Surveillance | 1 | 2018 | 3129 | 0.07 | Why? |
| Cat Diseases | 2 | 2021 | 539 | 0.07 | Why? |
| Female | 16 | 2021 | 380317 | 0.07 | Why? |
| Dog Diseases | 2 | 2021 | 745 | 0.07 | Why? |
| Protein Binding | 1 | 2021 | 11430 | 0.07 | Why? |
| Cats | 2 | 2021 | 1890 | 0.07 | Why? |
| Pneumonia, Viral | 7 | 2020 | 243684 | 0.07 | Why? |
| Middle Aged | 11 | 2021 | 270681 | 0.07 | Why? |
| Cytokines | 3 | 2021 | 15010 | 0.07 | Why? |
| Coronavirus Infections | 7 | 2020 | 253789 | 0.07 | Why? |
| Dogs | 2 | 2021 | 2529 | 0.06 | Why? |
| Virus Replication | 3 | 2020 | 14331 | 0.06 | Why? |
| Neoplasms | 1 | 2010 | 17251 | 0.06 | Why? |
| Prevalence | 3 | 2021 | 25773 | 0.06 | Why? |
| Cerebrospinal Fluid Pressure | 1 | 2020 | 17 | 0.06 | Why? |
| Mortality | 1 | 2018 | 7132 | 0.06 | Why? |
| Antibodies, Viral | 3 | 2021 | 51949 | 0.05 | Why? |
| Ultracentrifugation | 1 | 2020 | 63 | 0.05 | Why? |
| Pan American Health Organization | 1 | 2020 | 31 | 0.05 | Why? |
| Pandemics | 9 | 2020 | 389249 | 0.05 | Why? |
| Spinal Puncture | 1 | 2020 | 95 | 0.05 | Why? |
| Coinfection | 1 | 2020 | 6820 | 0.05 | Why? |
| Aged | 7 | 2020 | 215776 | 0.05 | Why? |
| Antibodies, Neutralizing | 3 | 2021 | 25288 | 0.05 | Why? |
| Antigen-Antibody Complex | 1 | 2021 | 408 | 0.05 | Why? |
| Animals, Domestic | 1 | 2021 | 272 | 0.05 | Why? |
| Infant, Newborn | 2 | 2018 | 23105 | 0.05 | Why? |
| Caribbean Region | 1 | 2020 | 349 | 0.05 | Why? |
| Vaccines, Combined | 1 | 2019 | 67 | 0.05 | Why? |
| Animals | 7 | 2021 | 78931 | 0.05 | Why? |
| Microscopy, Electron, Transmission | 1 | 2021 | 605 | 0.05 | Why? |
| Acids, Carbocyclic | 1 | 2017 | 27 | 0.05 | Why? |
| Ribonucleotides | 1 | 2018 | 96 | 0.04 | Why? |
| Cell Death | 1 | 2020 | 536 | 0.04 | Why? |
| RNA, Viral | 3 | 2021 | 32276 | 0.04 | Why? |
| Cross Infection | 1 | 2020 | 8675 | 0.04 | Why? |
| Cyclopentanes | 1 | 2017 | 55 | 0.04 | Why? |
| Endoplasmic Reticulum | 1 | 2021 | 430 | 0.04 | Why? |
| Pyrans | 1 | 2017 | 56 | 0.04 | Why? |
| Microbial Sensitivity Tests | 2 | 2017 | 2886 | 0.04 | Why? |
| Zanamivir | 1 | 2017 | 63 | 0.04 | Why? |
| Endocytosis | 1 | 2021 | 451 | 0.04 | Why? |
| Mumps | 1 | 2019 | 110 | 0.04 | Why? |
| Neutrophil Infiltration | 1 | 2018 | 201 | 0.04 | Why? |
| Rectum | 1 | 2021 | 495 | 0.04 | Why? |
| Viral Proteins | 1 | 2016 | 7370 | 0.04 | Why? |
| Phylogeography | 1 | 2021 | 824 | 0.04 | Why? |
| Time Factors | 1 | 2019 | 31397 | 0.04 | Why? |
| Nucleocapsid | 1 | 2021 | 734 | 0.04 | Why? |
| Sialic Acids | 1 | 2017 | 218 | 0.04 | Why? |
| Chickenpox | 1 | 2019 | 194 | 0.04 | Why? |
| MAP Kinase Signaling System | 1 | 2018 | 360 | 0.04 | Why? |
| Virus Assembly | 1 | 2018 | 438 | 0.04 | Why? |
| Prospective Studies | 3 | 2021 | 43301 | 0.04 | Why? |
| Genetic Association Studies | 1 | 2018 | 559 | 0.04 | Why? |
| Spatio-Temporal Analysis | 1 | 2021 | 1182 | 0.04 | Why? |
| Acute Disease | 2 | 2020 | 6029 | 0.03 | Why? |
| Influenza A Virus, H3N2 Subtype | 1 | 2019 | 572 | 0.03 | Why? |
| Latin America | 1 | 2020 | 1721 | 0.03 | Why? |
| Inhibitory Concentration 50 | 1 | 2017 | 907 | 0.03 | Why? |
| Picornaviridae | 1 | 2014 | 123 | 0.03 | Why? |
| Virus Shedding | 1 | 2010 | 5834 | 0.03 | Why? |
| Crystallography, X-Ray | 1 | 2021 | 2689 | 0.03 | Why? |
| World Health Organization | 2 | 2017 | 4213 | 0.03 | Why? |
| China | 1 | 2020 | 50654 | 0.03 | Why? |
| Guanidines | 1 | 2017 | 499 | 0.03 | Why? |
| Mice, Knockout | 1 | 2018 | 1815 | 0.03 | Why? |
| Sentinel Surveillance | 1 | 2020 | 1093 | 0.03 | Why? |
| Oropharynx | 1 | 2021 | 1581 | 0.03 | Why? |
| Immunization Schedule | 1 | 2019 | 1305 | 0.03 | Why? |
| Cysteine Endopeptidases | 1 | 2020 | 1557 | 0.03 | Why? |
| Ribavirin | 1 | 2018 | 1182 | 0.03 | Why? |
| Antigens, Viral | 1 | 2008 | 6298 | 0.03 | Why? |
| Severity of Illness Index | 1 | 2018 | 48226 | 0.03 | Why? |
| Family Characteristics | 1 | 2021 | 2551 | 0.03 | Why? |
| Amino Acid Substitution | 1 | 2017 | 1706 | 0.03 | Why? |
| Headache | 1 | 2020 | 2257 | 0.03 | Why? |
| Serologic Tests | 1 | 2003 | 4359 | 0.02 | Why? |
| History, 21st Century | 1 | 2016 | 1849 | 0.02 | Why? |
| Nasal Lavage Fluid | 1 | 2008 | 43 | 0.02 | Why? |
| Protein Domains | 1 | 2021 | 6563 | 0.02 | Why? |
| Monocytes | 1 | 2020 | 2978 | 0.02 | Why? |
| Double-Blind Method | 1 | 2019 | 5988 | 0.02 | Why? |
| Aged, 80 and over | 1 | 2018 | 88759 | 0.02 | Why? |
| Neutralization Tests | 1 | 2021 | 6698 | 0.02 | Why? |
| Odds Ratio | 1 | 2019 | 5861 | 0.02 | Why? |
| Mice, Inbred C57BL | 1 | 2018 | 5542 | 0.02 | Why? |
| Fluorescent Antibody Technique, Indirect | 1 | 2008 | 393 | 0.02 | Why? |
| Dose-Response Relationship, Drug | 1 | 2016 | 3776 | 0.02 | Why? |
| Drug Therapy, Combination | 1 | 2020 | 7268 | 0.02 | Why? |
| Hospital Mortality | 1 | 2010 | 22087 | 0.02 | Why? |
| Leadership | 1 | 2020 | 2241 | 0.02 | Why? |
| Multiplex Polymerase Chain Reaction | 1 | 2014 | 1439 | 0.02 | Why? |
| Comorbidity | 1 | 2010 | 34796 | 0.02 | Why? |
| Lopinavir | 1 | 2020 | 4308 | 0.02 | Why? |
| Longitudinal Studies | 1 | 2021 | 9893 | 0.02 | Why? |
| Immunization, Passive | 1 | 2021 | 10067 | 0.02 | Why? |
| Polymorphism, Single Nucleotide | 1 | 2018 | 3607 | 0.02 | Why? |
| Molecular Docking Simulation | 1 | 2020 | 6902 | 0.02 | Why? |
| Age Distribution | 1 | 2014 | 3567 | 0.02 | Why? |
| Protease Inhibitors | 1 | 2020 | 3630 | 0.02 | Why? |
| Cell Culture Techniques | 1 | 2008 | 704 | 0.02 | Why? |
| Radiography, Thoracic | 1 | 2020 | 5486 | 0.02 | Why? |
| Global Health | 2 | 2017 | 13911 | 0.02 | Why? |
| Viral Nonstructural Proteins | 1 | 2020 | 4810 | 0.02 | Why? |
| Disease Outbreaks | 1 | 2011 | 27595 | 0.02 | Why? |
| Phylogeny | 1 | 2021 | 13341 | 0.01 | Why? |
| Virus Internalization | 1 | 2021 | 7921 | 0.01 | Why? |
| Antibodies, Monoclonal | 1 | 2021 | 8041 | 0.01 | Why? |
| Case-Control Studies | 1 | 2020 | 17671 | 0.01 | Why? |
| Outpatients | 1 | 2014 | 3417 | 0.01 | Why? |
| CD8-Positive T-Lymphocytes | 1 | 2018 | 5837 | 0.01 | Why? |
| Databases, Factual | 1 | 2016 | 6248 | 0.01 | Why? |
| Disease Models, Animal | 1 | 2018 | 10998 | 0.01 | Why? |
| Bronchoalveolar Lavage Fluid | 1 | 2008 | 2309 | 0.01 | Why? |
| Mice | 1 | 2018 | 21357 | 0.01 | Why? |
| Biomarkers | 1 | 2021 | 23361 | 0.01 | Why? |
| Pregnancy | 1 | 2019 | 23879 | 0.01 | Why? |
| Health Services Accessibility | 1 | 2020 | 10697 | 0.01 | Why? |
| Nasopharynx | 1 | 2014 | 10224 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2020 | 53120 | 0.01 | Why? |
| Treatment Outcome | 1 | 2019 | 51732 | 0.01 | Why? |
| Communicable Disease Control | 1 | 2020 | 29620 | 0.01 | Why? |
| Retrospective Studies | 1 | 2020 | 105322 | 0.01 | Why? |
| Incidence | 1 | 2008 | 25622 | 0.00 | Why? |
| Coronavirus | 1 | 2014 | 18339 | 0.00 | Why? |
Siqueira's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(207)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(344)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_